No final decision has been made. If Walgreens decides to sell the unit, named iA, to interested parties such as rival healthcare organizations and private equity firms, it could make space for Summit Health, which Walgreens’ affiliate VillageMD bought for $8.9 billion in January, according to Bloomberg.
Walgreens’ iA is a pharmacy automation solutions segment that helps pharmacies fill prescriptions for mail-order transactions, according to its site.
